Perturbations of gut microbiome genes in infants with atopic dermatitis according to feeding type.
2018The Journal of allergy and clinical immunology
Direct disease-relevant human paper with strong clinical, biomarker, or mechanistic framing.
supportedmidmoderate inflation risk
Veillonella
atopic dermatitis
Veillonella is an interesting but still moderate-confidence signal in atopic dermatitis.
Veillonella shows a moderate evidence base in atopic dermatitis, with multiple central papers and additional supporting literature.
veillonella
Credibility score
12
Human translation
5/5
Reproducibility
2/5
Novelty
4/5
Actionability
2/5
Credibility 12Human translation 5/5Reproducibility 2/5Novelty 4/5Actionability 2/5
Why this scores the way it does
- moderate central evidence base
Main caveats
- directionality and confounding still require curated review
Primary central evidence
5 papersThe associations of maternal and children's gut microbiota with the development of atopic dermatitis for children aged 2 years.
2022Frontiers in immunology
Direct disease-relevant human paper with strong clinical, biomarker, or mechanistic framing.
Oropharyngeal Microbiota Clusters in Children with Asthma or Wheeze Associate with Allergy, Blood Transcriptomic Immune Pathways, and Exacerbation Risk.
2023American journal of respiratory and critical care medicine
Direct disease-relevant human paper with strong clinical, biomarker, or mechanistic framing.
An Observational Study: Association Between Atopic Dermatitis and Bacterial Colony of the Skin Based on 16S rRNA Gene Sequencing.
2024Clinical, cosmetic and investigational dermatology
Direct disease-relevant human paper with strong clinical, biomarker, or mechanistic framing.
The association between the composition of the early-life intestinal microbiome and eczema in the first year of life.
2023Frontiers in microbiomes
Direct disease-relevant human paper with strong clinical, biomarker, or mechanistic framing.
Preclinical supporting evidence
1 papersRegulation of Peripheral Inflammation by a Non-Viable, Non-Colonizing Strain of Commensal Bacteria.
2022Frontiers in immunology
Disease-relevant preclinical or model-based paper useful as supporting evidence.